Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and end

Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and end

Item

http://www.wikidata.org/entity/Q35231198

Q35231198

about

Vascular endothelial dysfunction and pharmacological treatment Antihypertensive drugs and glucose metabolism Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells.Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study.Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients.Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions.Exercise-based cardiac rehabilitation improves endothelial function assessed by flow-mediated dilation but not by pulse amplitude tonometry.A retrospective longitudinal cohort study of antihypertensive drug use and new-onset diabetes in Taiwanese patients.Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers.Azelnidipine, Not Amlodipine, Induces Secretion of Vascular Endothelial Growth Factor From Smooth Muscle Cells and Promotes Endothelial Tube Formation.Amlodipine Ameliorates Ischemia-Induced Neovascularization in Diabetic Rats through Endothelial Progenitor Cell Mobilization.Mibefradil reduces blood glucose concentration in db/db mice Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Effect of intensive multifactorial treatment on vascular progenitor cells in hypertensive patients.Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets.Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes.Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies.Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways

P2860

Q26774561-50657D2A-A846-46E6-8970-B4F0AD96D5EA Q33948469-E11C09A0-4F24-4221-A01F-420F54A798D5 Q35566830-0D6767AA-DA1F-403E-9438-8D9F9DBC8CB1 Q35602720-902E2DCF-55FE-4346-BE75-B17482B93820 Q35856525-2A009A36-28AA-4843-A879-79900E73D853 Q36112416-971A7586-4DF6-4F0C-8AFB-E3C138774B8A Q36194828-176DD5D6-648F-42B6-A070-7439EA54BFD6 Q37073212-C509C804-9A06-4220-9DA9-46617141E4BD Q37326200-46E3890B-87BA-4185-9B6D-C34C7BE5C26C Q38272734-35ED1313-5515-45EF-9139-2183530133C3 Q39717221-9296944C-BF82-46DF-AE3C-B83060EA6FD5 Q40061772-F6386C68-0187-4A1D-B3FA-8FF6CB547706 Q41481131-93321D05-E435-455B-B50C-CD67B98953B0 Q41867019-EFB79107-C8AA-43AD-B5AC-92CAB2550115 Q41982703-F1F6429C-4197-4094-AB28-7BA728F16A8E Q41986164-38C3CFE1-4E93-40EA-8B97-44CA22DED982 Q42051393-27863281-9F5C-4D31-B343-AD0119DBE360 Q46960793-97056D3C-CBCA-49A7-82BB-E651C63260B3 Q47557757-8570CB54-95A2-49D9-ADA8-0F3950DF4DE1 Q48302634-86C99C36-7FB3-4DB2-AA50-E927CAE19D12 Q48512017-8E3D099E-734D-4645-9F0F-B1451D24CACB Q49418865-5A872F59-C575-4BEC-A725-62DD2CA1361E Q50866529-80A8FDB2-017D-4B5F-A55A-208DB6666F44 Q51351838-EB782D1B-CB8C-46E6-A48A-B5C1C902F8F2 Q59138098-45F65493-67FF-4694-92C3-9143FA395ED1

P2860

Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and end

Item

http://www.wikidata.org/entity/Q35231198

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu